Latest Breaking News On - Oncotelic inc - Page 1 : comparemela.com

Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results

DelveInsight Business Research, LLP: Extremely Robust COVID-19 Clinical Trial Pipeline With 420+ Key Companies Expected to Change the Pace of the COVID-19 Treatment

COVID-19 clinical trial pipeline constitutes 420+ key companies continuously working towards developing 520+ COVID-19 vaccines and drugs, analyzes DelveInsight LAS VEGAS, Nov. 8, 2022 /PRNewswire/

Oncotelic Announces Formation of Animal Health Division

AGOURA HILLS, Calif., Oct. 06, 2022 Oncotelic Therapeutics, Inc , directly and / or through its wholly owned subsidiaries Oncotelic Inc. and PointR Data Inc., a developer of treatments for rare. | October 6, 2022

Global COVID-19 Pipeline Report 2021 - Comprehensive Insights About 400+ Companies and 400+ Pipeline Drugs

/PRNewswire/ The "COVID-19 - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com s offering. This "COVID-19 - Pipeline Insight,.

Oncotelic Hopes to Leverage Intranasal Apomorphine to Treat Parkinson's Disease

Clinical trials have demonstrated that intermittent apomorphine injections provide rapid and effective relief from sudden, unexpected “off” periods brought on by primary Parkinson’s medicine, levodopa.